undamentalytics Newsletter
Sign in

Genelux Corp balance sheet

At the end of fiscal 2025, Genelux Corp had total assets of $19.0m, total liabilities of $7.5m and shareholders' equity of $11.5m. It held $5.3m in cash against $0 of debt: net cash of $5.3m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Cash and equivalents0995
Total current assets2243215
Total assets6283519
Deferred revenue (current)0———
Total current liabilities32776
Short-term debt—1——
Total debt24100
Total liabilities41887
Shareholders' equity−36192612
Net debt (negative = net cash)24−9−9−5
Shares outstanding9m27m35m38m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CELZ vs GNLXGNLX vs LYELAIM vs GNLX

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Genelux Corp's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Genelux Corp.